Kowa Research Institute, Inc.
Clinical trials sponsored by Kowa Research Institute, Inc., explained in plain language.
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedThis study tested an eye drop called ripasudil (K-321) in 110 people with Fuchs endothelial corneal dystrophy who had cataract and cornea surgery. The goal was to see if the drops help vision improve faster and safely. Participants used the drops for 12 weeks, then stopped gradua…
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 26, 2026 07:40 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedThis study tested whether ripasudil eye drops can help people with Fuchs endothelial corneal dystrophy recover vision faster after a specific cornea surgery (descemetorhexis). 107 adults participated, receiving either the eye drops or a placebo for 12 weeks, followed by a gradual…
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC